SARS-CoV-2 seroprevalence in Spain - Authors' reply

Lancet. 2020 Nov 7;396(10261):1484-1485. doi: 10.1016/S0140-6736(20)32266-2.

¹ National Centre for Epidemiology, Institute of Health Carlos III, 28029 Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health, Institute of Health Carlos III, 28029 Madrid, Spain. Electronic address: [email protected].
² National Centre for Epidemiology, Institute of Health Carlos III, 28029 Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health, Institute of Health Carlos III, 28029 Madrid, Spain.
³ National Centre for Microbiology, Institute of Health Carlos III, 28029 Madrid, Spain; Spanish Network for Research in Infectious Diseases, Institute of Health Carlos III, 28029 Madrid, Spain.
⁴ National Centre for Microbiology, Institute of Health Carlos III, 28029 Madrid, Spain.
⁵ Directorate, Institute of Health Carlos III, 28029 Madrid, Spain.

No abstract available

Publication types